I am a UKRI Innovation Fellow at Health Data Research UK and Clinical Reader in Rheumatology. I moved to Imperial College as a Group Leader in 2019.
My group’s research lies at the interface of molecular epidemiology, computational biology and clinical medicine. Our focus is understanding the molecular and cellular basis of immune-mediated inflammatory diseases using a combination of genomics, transcriptomics and proteomics. We employ a wide range of techniques including longitudinal molecular profiling, polygenic risk scores, and Mendelian randomisation, leveraging both our own in-house datasets and also publically available resources (eg GWAS summary statistics, UK Biobank).
et al., 2021, Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death, Elife, ISSN:2050-084X
et al., 2020, Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals, Nature Metabolism, Vol:2, Pages:1135-+
et al., 2019, Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status, Nature Communications, Vol:10, ISSN:2041-1723
et al., 2018, Reduced monocyte and macrophage TNFSF15/TL1A expression is associated with susceptibility to inflammatory bowel disease, PLOS Genetics, Vol:14, ISSN:1553-7390
et al., 2018, Genomic atlas of the human plasma proteome, Nature, Vol:558, ISSN:0028-0836, Pages:73-79
et al., 2016, Insight into genotype-phenotype associations through eQTL mapping in multiple cell types in health and immune-mediated disease, PLOS Genetics, Vol:12, ISSN:1553-7390, Pages:1-29